-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

704. Cellular Immunotherapies: Early Phase and Investigational Therapies: Poster II

Symposia: Cellular Immunotherapies: Early Phase and Investigational Therapies Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 10, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Martin Wermke, MD1*, Stephan Metzelder2*, Sabrina Kraus, MD3*, Elisa Sala, MD4*, Vladan Vucinic, M.D.5*, Walter Fiedler, MD6, Katrin Wetzko7*, Jonas Schäfer8*, Maria-Elisabeth Goebeler9*, Jan Koedam, MSc10*, Kristin Franke10*, Matti Vänskä11*, Armin Ehninger10*, Marc Cartellieri, PhD10*, Gerhard Ehninger, M.D.12 and Tapan Maniar13*

1Department of Internal Medicine I, University Hospital Dresden, Dresden, Germany
2Philipps-Universität Marburg, Marburg, Germany
3Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
4Universitätrklinikum Ulm, Ulm, DEU
5Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Germany
6University Hospital Hamburg-Eppendorf, Hamburg, DEU
7Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany
8Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Gießen and Marburg and Carreras Leukemia Center, Marburg, Germany
9Universitätsklinikum Würzburg, Wuerzburg, DEU
10AvenCell Europe GmbH, Dresden, Germany
11AvenCell Europe GmbH, Heidelberg, Germany
12Universitatsklinikum Carl Gustav Carus Medizinische Klinik und Poliklinik I, Dresden, DEU
13AvenCell Therapeutics, Inc., Cambridge

Yinqiang Zhang1,2*, Mengyi Du1,2*, Danying Liao1,2*, Wei Xie1,2*, Wei Xiong3* and Heng Mei1,2*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China
3Wuhan Sian Medical Technology Co., Ltd, Wuhan, China

Colleen Annesley, MD1,2, Kristy Seidel3*, Qian Vicky Wu, PhD4*, Corinne Summers, MD2,4*, Alan S. Wayne, MD5, Anurag K. Agrawal, MD6*, Michael A. Pulsipher, MD7*, Christopher Brown2*, Stephanie Mgebroff2*, Catherine Lindgren2*, Ashley L. Wilson, PhD2*, Wenjun Huang2*, Julie R. Park, MD8*, Michael C. Jensen, MD2* and Rebecca A. Gardner, MD8*

1Seattle Children's Hospital, Seattle
2Seattle Children's Therapeutics, Seattle, WA
3Seattle Children's Therapeutics, Seattle
4Fred Hutchinson Cancer Research Center, Seattle, WA
5Children's Hospital of Los Angeles, Los Angeles, CA
6UCSF Benioff Children's Hospital, Oakland, CA
7University of Utah School of Medicine, Salt Lake City, UT
8St. Jude Children's Research Hospital, Memphis, TN

Yang Xu1,2*, Xuzhao Zhang1*, Dijia Xin1*, Jiawei Zhang1*, Luyao Wang1*, Yili Fan1*, Boxiao Chen1*, Wen Lei1*, Xi Qiu1*, Huawei Jiang1*, Xibin Xiao1*, Liansheng Huang1*, Wenjun Yang3*, Jiangao Zhu3* and Wenbin Qian1*

1The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute, Zhejiang University,, Hangzhou, China
3Carbiogene Therapeutics Ltd., Hangzhou, China

Shuntaro Ikegawa, MD, PhD1*, Adam S. Sperling, MD, PhD1, Michela Ansuinelli, MD1*, Sarah Nikiforow, MD, PhD1, David Quinn, BA2*, Dexiu Bu, MD, PhD2*, Jennifer Mataraza, PhD2*, David Pearson, PhD2*, Lawrence Rispoli, BA2*, Marc A Credi, MA2*, Nina Orwitz, PhD3*, Yohei Arihara, MD, PhD1*, Rao Prabhala, PhD1*, Lakshmi Bhavani Potluri, MD4, Carol Reynolds, PhD1*, Serena De Vita, MD, PhD2*, Nikhil C Munshi, MD1* and Jerome Ritz, MD1

1Dana-Farber Cancer Institute, Boston, MA
2Novartis Institutes for BioMedical Research, Cambridge, MA
3Novartis Pharmaceuticals Corporation, Basel, Switzerland
4Wayne State University Sinai Grace Hospital, Detroit, MI

Michael Slade, MD, MSCI1, Michael P. Rettig, PhD1, Zachary David Crees, MD2, Neha Mehta-Shah, MD1, Todd A Fehniger, MD, PhD1, Amanda F Cashen1, Iskra Pusic1, Geoffrey L Uy, MD1, Peter Westervelt, MD1, John DiPersio1 and Armin Ghobadi, MD1

1Division of Oncology, Washington University School of Medicine, Saint Louis, MO
2Division of Oncology, Washington University School of Medicine, Frontenac, MO

Lijuan Hu1*, Hui Yu, PhD, MD2*, Heng Mei3*, Dehui Zou4*, Yaqing Li5*, Danying Liao3*, Wei Liu, MD6*, Yan Xu, MD6*, Lei Zhang, MD5*, Xudong Zhang2*, Zhenchang Sun, PhD, MD2*, Xinhua Wang, PhD, MD2*, Min Wang7*, Fengtao You8*, Huimin Meng8*, Tian Wang8*, Bozhen Zhang7,8*, Lin Yang, PhD7,8, Mingzhi Zhang5* and Xiaojun Huang, MD1*

1Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Bejing, China
2Department of Oncology, The First Affiliated Hospital of Zhengzhou University&Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, Henan, China
3Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
4State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
5Department of Oncology, The First Affiliated Hospital of Zhengzhou University&Lymphoma Diagnosis and Treatment Center of Henan Province, Zhengzhou, China
6State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
7PersonGen-Anke Cellular Therapeutics Co., Ltd., Hefei, China
8PersonGen BioTherapeutics (Suzhou) Co., Ltd., Suzhou, China

Shiqi Li, MD1*, Zhongtao Yuan, MD2*, Lin Liu2*, Yu Li, MD1*, Le Luo, MD2*, Yingnian Chen, MD1*, Lihua Zhang, MD1*, Guangchao Li, PhD3*, Min Luo, PhD4*, Kaikai Zeng, PhD5*, Donghui Ma, PhD5* and Sanbin Wang Sr., MD, PhD2*

1920th Hospital of Joint Logistics Support Force, Kunming, China
2Department of Hematology, 920th Hospital of Joint Logistics Support Force, Kunming, China
3Guangzhou Bio-gene Technology Co., Ltd, Guangzhou, China
4Guangzhou Bio-gene Technology Co., Ltd, GUANGZHOU, China
5DIMA Biotechnology, LTD, Wuhan, China

Joseph Rimando, MD1, Francesco Mazziotta2*, Alison Gareau, PhD3*, Maria Bettinotti, PhD3, Jonathan Allen Webster, MD4, Syed Abbas Ali5, Philip Imus, MD5, Mario Victor Lemas5*, Amy E. DeZern, MD, MHS6, Mark J. Levis, MD, PhD7, Marianna Zahurak, MS8*, Ravi Varadhan5*, Richard F. Ambinder, MD9, Carol Huff, MD6, Ivana Gojo, MD5, Richard J. Jones, MD4, Ivan M. Borrello, MD4 and Leo Luznik, MD10

1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, Johns Hopkins University School of Medicine, ATLANTA, GA
2Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, Johns Hopkins University School of Medicine, Baltimore, MD, Baltimore, MD
3Johns Hopkins University School of Medicine, Baltimore, MD
4Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD
5Johns Hopkins, Baltimore, MD
6Johns Hopkins University, Baltimore, MD
7Division of Hematologic Malignancies, Johns Hopkins University, Baltimore, MD
8Johns Hopkins, Balitmore
9Johns Hopkins University Bunting-Blaustein Cancer Rsch. Bldg., Baltimore, MD
10Sidney Kimmel Comprehensive Cancer Ctr., Baltimore, MD

Ashish Bajel, FRACP1, Sylvain Garciaz2*, Pinkal Desai, MD, MPH3, Gerwin A Huls, MD, PhD4*, Abhishek Maiti, MD5, Mojca Jongen-Lavrencic, MD, PhD6, Nicolas Boissel, MD, PhD7*, Stephane De Botton, MD, PhD8*, David C. de Leeuw, MD, PhD9*, Shaun Fleming10*, C. Michel Zwaan, MD11*, Martha Arellano12, David Avigan, MD13, Jennifer N. Saultz, DO14, Ioannis Mantzaris15, Kyle Jensen, PhD, MS, MBA16, Timothy Wagenaar, PhD16*, Gu Mi, PhD16*, Samira Ziti-Ljajic, Masters 2 (M2)17*, Dobrin Draganov, PhD16*, Giovanni Abbadessa, MD, PhD16 and Anthony Selwyn Stein, MD18

1Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia
2Institut Paoli-Calmettes, Marseille, France
3Weill Cornell Medicine, New York, NY
4University Medical Center Groningen, Groningen, Netherlands
5Department of Leukemia, MD Anderson Cancer Center, Houston, TX
6Erasmus University Medical Center, Rotterdam, Netherlands
7Hôpital Saint-Louis, Paris, France
8Institut Gustave Roussy, Paris, France
9Amsterdam University Medical Center, Amsterdam, Netherlands
10Alfred Health, Melbourne, Australia
11Prinses Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands
12Emory University School of Medicine, Atlanta, GA
13Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
14Oregon Health & Science University, Portland, OR
15Department of Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
16Sanofi, Cambridge, MA
17Sanofi, Chilly-Mazarin, France
18City of Hope National Medical Center, Duarte, CA

Marianna Ponzo, PhD1,2*, Lorenzo Drufuca, PhD3,4*, Chiara Buracchi, PhD, MSc1,2*, Silvia Nucera, MD1,2*, Cristina Bugarin, MSc1*, Grazisa Rossetti, PhD3*, Raoul Bonnal3*, Benedetta Rambaldi, PhD5*, Andrea Biondi, MD6,7, Giuseppe Gaipa, PhD1, Massimiliano Pagani, Prof.3,4* and Chiara Francesca Magnani, Prof.1,8*

1Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
2School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
3The AIRC Institute of Molecular Oncology (IFOM), Milan, Italy
4Department of Medical Biotechnology and Translational Medicine, Università degli Studi, Milan, Italy
5Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
6School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy
7Pediatrics, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy
8Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland

Sanam Shahid, MD1, Georgia C Flynn1*, Audrey Mauguen, PhD2*, Jennifer Bieler1*, Susan E Prockop, MD3*, Andromachi Scaradavou, MD1, Jaap Jan Boelens, MD1, Craig S Sauter, MD4, Miguel-Angel Perales, MD5, Sergio A. Giralt, MD, FACP6, Xiuyan Wang, PhD7*, Isabelle Riviere, PhD7, Michel Sadelain, MD PhD8, Renier Brentjens, MD PhD9, Nancy A Kernan, MD1, Richard J O'Reilly, MD1* and Kevin J Curran, MD1

1Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
2Epidemiology-Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
3Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
4Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
5Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY
8Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY
9Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Liqing Kang1*, Shengli Xue2*, Xiaowen Tang2*, Xiaoyan Lou1*, Chongsheng Qian2*, Wenjie Gong2*, Mingzhu Xu2*, Haixia Zhou2*, Zhen Yao2*, Wei Wang1*, Minghao Li1*, Nan Xu1*, Zhou Yu1*, Suning Chen2*, Huiying Qiu3*, Haiping Dai2*, Yang Xu, M.D.4*, Depei Wu2,5 and Lei Yu1*

1Shanghai Unicar-Therapy Bio-Medicine Technology Co.,Ltd, Shanghai, China
2The First Affiliated Hospital of Soochow University, Suzhou, China
3Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
4National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
5National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China

Monica A Moreno, PhD1*, Jackie Kennedy-Wilde, MS1*, Andrew D Wrong, MS1*, Nadine Jahchan, PhD1*, Francesco Galimi, MD, PhD1, Yining Ye, PhD1*, Rose Lai, MD1* and Blake T Aftab, PhD2

1Adicet Therapeutics, Inc, Redwood City, CA
2Adicet Therapeutics, Inc, San Ramon, CA

Bhagirathbhai Dholaria, MBBS1,2, Mehmet H. Kocoglu, MD3, Andrew Kin, MD4, Adam S. Asch, MD5*, Aravind Ramakrishnan, M.D.6, Carlos Bachier, MD7, Tulio E. Rodriguez, MD8, Leyla Shune, MD9, Katherine McArthur10*, Joanne McCaigue11*, Samuel DePrimo10*, Chris Martin, PhD11*, Sabrina Haag12*, Maggie Zhang, PharmD11*, Hamid Namini, PhD13*, Ellen Christie, BS11*, Rajesh Belani, MD11*, Stacey A Cranert, PhD11*, Julia Coronella, PhD11*, Devon J Shedlock, PhD11 and Caitlin L. Costello, MD14

1Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
2Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN
3University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
4Karmanos Cancer Institute/Wayne State University, DETROIT, MI
5University of Oklahoma Health Sciences Center, Oklahoma City, OK
6Sarah Cannon Transplant and Cellular Therapy Program at St. David's South Austin Medical Center, Austin, TX
7Sarah Cannon Transplant and Cellular Therapy Program at Methodist Hospital, San Antonio, TX
8Advocate Lutheran General Hospital, Park Ridge, IL
9Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
10Poseida Therapeutics, San Deigo, CA
11Poseida Therapeutics, San Diego, CA
12Poseida Therapeutics, San Deigo
13Poseida Therapeutics, San Diego
14University of California, San Diego, La Jolla, CA

Liping Zhao1*, Qi Zhou2*, Chen Chen2*, Zhuojun Ling3*, Kai Wang3*, Fan Wu3*, Jinlong Xu3*, Jiajia Duan3*, Zelin Wang3*, Quangang Wang3* and Jing PAN, MD, PhD3

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Gobroad Research Center, Beijing, China
3Beijing GoBroad Boren Hospital, Beijing, China

Yan Qiu1*, Chong-Sheng Qian1*, Hai-Xia Zhou1*, Ming-Zhu Xu1*, Li-Qing Kang2*, Ai-Ning Sun1*, De-Pei Wu3, Lei Yu2* and Sheng-Li Xue1*

1The First Affiliated Hospital of Soochow University, Suzhou, China
2Shanghai Unicar-Therapy Bio-Medicine Technology Co.,Ltd, Shanghai, China
3Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China

QI Deng1*, Jia Wang, DO2*, Rui Cui, MD3*, Juan Mu2*, Xin Li4*, Qing Li5* and Lugui Qiu6,7

1Tianjin First Centre Hospital, TIANJIN, CHN
2Department of Hematology, Tianjin First Central Hospital, Tianjin, China
3Department of hematology, Tianjin First center hospital, Tianjin, China
4Tianjin First Centre Hospital, Tianjin, China
5Tianjin First Central Hospital, Tianjin, China
6State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
7Tianjin Institutes of Health Science, Tianjin, China

Valentin Ortiz-Maldonado, MD1*, Nuria Martinez-Cibrian, MD2*, Gonzalo Del Campo Balguerías, MD3*, Marta Español-Rego, MD, PhD4*, Sergio Navarro, Biochem4*, Irene Lopez-Oreja, MD, PhD5*, Ferran Nadeu, PhD6*, Amparo Cobo, MD7*, Helena Brillembourg, MD8*, Leticia Alserawan, Phar9*, Maria Castella, PhD9*, Daniel Benitez-Ribas, PhD10*, Laura Magnano, MD, PhD8*, Juan Gonzalo Correa, MD11*, Andrea Rivero, MD12*, Pablo Mozas, MD, PhD13*, Eva Gine, MD14, Luis Gerardo Rodríguez-Lobato, MD, PhD12*, Alexandra Martínez-Roca, MD15*, Mercedes Montoro-Lorite, RN13*, Pilar Ayora, RN8*, Carlos Fernández de Larrea16*, Mariona Pascal, PhD9*, Xavier Setoain7*, Jordi Esteve Reyner, MD, PhD8*, Alvaro Urbano-Ispizua Sr., MD8, Manel Juan, MD, PhD17* and Julio Delgado2*

1Hospital Clinic, Barcelona, Spain
2Hospital Clínic de Barcelona, Barcelona, Spain
3Department of Hematology, Hospital Clínico San Carlos, Madrid, Spain
4Department of Immunology, Hospital Clínic, Barcelona, Spain
5Hematopathology section, Hospital Clínic, IDIBAPS, Barcelona, ESP
6IDIBAPS, Barcelona, ESP
7Nuclear Medicine Unit, Hospital Clínic, Barcelona, Spain
8Department of Hematology, Hospital Clínic, Barcelona, Barcelona, Spain
9Department of Immunology, Hospital Clínic, Barcelona, Barcelona, Spain
10Department of Immunology, Hospital Clínic, Barcelona, Barcelona, ESP
11Department of Hematology, Hospital Clínic, Barcelona, Spain
12Department of Hematology, Hospital Clínic, Barcelona, ESP
13Department of Hematology, Hospital Clínic, Barcelona, Barcelona, ESP
14Hospital Clinic of Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
15Hematology Department, Hospital Clinic de Barcelona, ICMHO, Barcelona, Spain
16Department of Haematology, Hospital Clínic, Barcelona, Spain
17Department of Immunology, Platform of Immunotherapy Clínic-Sant Joan de Déu, Hospital Clínic, Barcelona, Spain

Bailin He, PhD1*, Hongsheng Zhou, MD1*, Ren Lin2*, Zhixiang Wang3*, Na Xu1*, Qiang Wang, MD1*, Jing Sun, Mphil, BEng4*, Xiaoli Liu1*, Peng Li, PhD5* and Qifa Liu, MD2

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
2Nanfang Hospital, Southern Medical University, Guangzhou, China
3Nanfang Hospital, Southern Medical University, Guangzhou, CHN
4Nanfang hospital of southern medical university, guangzhou, China
5Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China

Jingjing Feng, MD1*, He Huang, MD2* and Yongxian HU3*

1The First affiliated Hospital, School of Medicine, Hangzhou, China
2Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China
3Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Yanmin Zhao, MD1,2,3,4*, Yi Luo1,2,3,4*, Jimin Shi2,3,4,5*, Jian Yu, MD1,2,3,4*, Lizhen Liu1,2,3,4*, Xiaoyu Lai2,3,4,6*, Huarui Fu2,3,4,5*, Yishan Ye, MD1,2,7,8*, Nainong Li, MD, PhD9,10, Erlie Jiang, PhD11, Jundong Gu, MD, PhD12*, Zhibo Han12*, Zhongchao Han, PhD12* and He Huang1,2,3,4*

1Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China, Hangzhou, China
2Zhejiang Laboratory for Systems and Precision Medicine, Zhejiang University Medical Center, Hangzhou, Zhejiang, People's Republic of China, Hangzhou, China
3Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China, Hangzhou, China
4Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China, Hangzhou, China
5Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
6Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China
7Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China
8Institute of Hematology, Zhejiang University, Hangzhou, China
9Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, fuzhou, China
10Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China
11State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
12National Engineering Research Centre of Cell Products, Tianjin Key Laboratory of Engineering Technologies for Cell Pharmaceutical, AmCellGene Engineering Co., Ltd, Tianjin, China

Sarita Rani Jaiswal, MD, BSc1,2,3*, Mahak Agarwal, MD4*, Prakash Baligar2*, Gitali Bhagawati, MD5*, Subhrajit Biswas2*, Bhudev C Das2*, Bipin N. Savani, MD6,7 and Suparno Chakrabarti, MD, MBBS, FRCPath3,4*

1Department of BMT and Hematology, Dharamshila Hospital & Research Centre, New Delhi, India
2Amity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University, Noida, India
3Cellular Therapy and Immunology, Manashi Chakrabarti Foundation, New Delhi, India
4Department of BMT and Hematology, Dharamshila Narayana SS Hospital & Research Centre, New Delhi, India
5Department of Microbiology and Pathology, Dharamshila Narayana SS Hospital & Research Centre, New Delhi, India
6Vanderbilt University, Brentwood, TN
7Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN

Sanfang Tu1*, Lijuan Zhou, MD1*, Rui Huang, MD2*, Yanjie He, MD1*, Xuan Zhou, MD1*, Jilong Yang, MD1*, Yuxing Hu, MD1*, Honghao Zhang, MD1*, Lung-Ji Chang, PhD3,4 and Yuhua Li1*

1Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
2Department of Hematology, Zhujiang Hospital, Southern Medical University, GUANGZHOU, AL, China
3School of Medicine, University of Electronic Science and Technology of China, Chengdu, Chengdu, China
4Geno-Immue Medical Institute, Shenzhen, China

Gaofeng Zheng, MD1*, Heng Mei2*, Gang Ye, MD3*, Ling Zhou3*, Cheng Wen3*, Zhuoxiao Cao3* and Zhen Cai, PhD, MD4*

1Bone Marrow Transplantation Center, Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, Hangzhou, China
2Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Shanghai Simnova Biotechnology Co., Ltd, Shanghai, China, Shanghai, China
4Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Benjamin R Puliafito, MD1, Christopher M Walthers, PhD2*, Brenda Ji2*, Sanaz N Ghafouri, MD2*, Jacob Naparstek2*, Jacqueline Trent2*, Jia Ming Chen, PhD3*, Mobina Roshandell3*, Caitlin Harris2*, Mobina Khericha, PhD2*, Melanie Ayala Ceja2*, Christy Sidhu2*, Thomas Schweppe2*, Beata Berent-Maoz, PhD2*, Stanley B Gosliner2*, Amr Almaktari2*, Karla Nawaly2*, Martin S Allen-Auerbach, MD2*, Jonathan Said, MD4, Monica Mead, MD2, Sven de Vos, MD, PhD5*, Patricia A. Young, MD5, Caspian H. Oliai, MD6, Gary J. Schiller, MD7, John Timmerman, MD2, Antoni Ribas, MD, PhD8*, Yvonne Y Chen, PhD2* and Sarah M. Larson, MD2

1University of California, Los Angeles, Santa Monica, CA
2University of California, Los Angeles, Los Angeles, CA
3Parker Institute for Cancer Immunotherapy Center at UCLA, Los Angeles, CA
4Department of Pathology & Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA
5Department of Medicine/Division of Hematology and Oncology, UCLA Medical Center, Los Angeles, CA
6Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA
7Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA
8University of California Los Angeles, Los Angeles, CA

Sining Liu1,2*, Qingya Cui1,2*, Zheng Li1,2*, Wei Cui1,2*, Mengyun Li1,2*, Huiying Qiu1,2*, Shengli Xue1,2*, Suning Chen, MD1,2*, Zhengming Jin1,2*, Miao Miao1,2*, Yue Han1,2*, Ying Wang1,2*, Xiaming Zhu1,2*, Lei Yu3*, Depei Wu, M.D.1,2 and Xiaowen Tang1,2*

1National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
2Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
3Shanghai Unicar-Therapy Bio-Medicine Technology Co.,Ltd, Shanghai, China

Sanfang Tu1*, Lijuan Zhou, MD1*, Rui Huang, MD2*, Xuan Zhou, MD1*, Jilong Yang, MD1*, Meifang Li, MD3*, Bo Jin, MD & PhD1*, Langqi Wang, MD1*, Yaqi Zhuo, MD1*, Huifang Chen, MD1*, Lung-Ji Chang, PhD4,5 and Yuhua Li1*

1Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
2Department of Hematology, Zhujiang Hospital, Southern Medical University, GUANGZHOU, AL, China
3Department of Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
4School of Medicine, University of Electronic Science and Technology of China, Chengdu, Chengdu, China
5Geno-Immue Medical Institute, Shenzhen, China

Nuttavut Sumransub, MD1, Cassie Seichter2*, Kateryna Kent2*, Ryan Shanley3*, Marie Hu, MD1, Daniel O'Leary, MD1, Najla El Jurdi, MD1, Shernan G. Holtan, MD4, Brian Betts, MD1, Mark Juckett, MD1, Jeremy R. Allred, MD1, Veronika Bachanova, MD, PhD1, Jeffrey S Miller, MD5 and Joseph E. Maakaron, MD1

1Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
2Masonic Cancer Center, University of Minnesota, Minneapolis, MN
3Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
4Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
5Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN

*signifies non-member of ASH